{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:20:13Z","timestamp":1773922813499,"version":"3.50.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1,1]]},"DOI":"10.1093\/jac\/dku344","type":"journal-article","created":{"date-parts":[[2014,9,3]],"date-time":"2014-09-03T06:18:30Z","timestamp":1409725110000},"page":"173-177","source":"Crossref","is-referenced-by-count":16,"title":["In vitro activities of the novel bicyclolides modithromycin (EDP-420, EP-013420, S-013420) and EDP-322 against MDR clinical Neisseria gonorrhoeae isolates and international reference strains"],"prefix":"10.1093","volume":"70","author":[{"given":"Susanne","family":"Jacobsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Golparian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ly T.","family":"Phan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Fredlund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yat Sun","family":"Or","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Unemo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,9,1]]},"reference":[{"key":"key\n\t\t\t\t20170425174217_DKU344C1","author":"WHO"},{"key":"key\n\t\t\t\t20170425174217_DKU344C2","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2217\/fmb.12.117","article-title":"Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea","volume":"7","year":"2012","journal-title":"Future Microbiol"},{"key":"key\n\t\t\t\t20170425174217_DKU344C3","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant N. gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure","volume":"56","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425174217_DKU344C4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2012.176575","article-title":"Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada","volume":"309","year":"2013","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170425174217_DKU344C5","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/jac\/dkt034","article-title":"Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure","volume":"68","year":"2013","journal-title":"J Antimicrobial Chemother"},{"key":"key\n\t\t\t\t20170425174217_DKU344C6","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1128\/AAC.00325-11","article-title":"Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425174217_DKU344C7","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1071\/SH13077","article-title":"One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500 mg ceftriaxone in Sydney, Australia","volume":"10","year":"2013","journal-title":"Sex Health"},{"key":"key\n\t\t\t\t20170425174217_DKU344C8","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/jac\/dkt017","article-title":"Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia","volume":"68","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425174217_DKU344C9","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/jac\/dks162","article-title":"Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain","volume":"67","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425174217_DKU344C10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0956462412472837","article-title":"2012 European guideline on the diagnosis and treatment of gonorrhoea in adults","volume":"24","author":"on behalf of the European STI Guidelines Editorial Board","year":"2013","journal-title":"Int J STD AIDS"},{"key":"key\n\t\t\t\t20170425174217_DKU344C11","first-page":"590","article-title":"Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20170425174217_DKU344C12","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1021\/ol048336r","article-title":"Synthesis of novel 6,11-O-bridged bicyclic ketolides via a palladium-catalyzed bis-allylation","volume":"6","year":"2004","journal-title":"Org Lett"},{"key":"key\n\t\t\t\t20170425174217_DKU344C13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1128\/AAC.49.1.281-288.2005","article-title":"Binding site of the bridged macrolides in the Escherichia coli ribosome","volume":"49","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425174217_DKU344C14","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1128\/AAC.01303-06","article-title":"EDP-420, a bicyclolide (bridged bicyclic macrolide), is active against Mycobacterium avium","volume":"51","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425174217_DKU344C15","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/jac\/dkq147","article-title":"In vitro antibacterial activities of S-013420, a novel bicyclolide, against respiratory tract pathogens","volume":"65","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425174217_DKU344C16","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1128\/AAC.01469-10","article-title":"In vitro antibacterial activity of modithromycin, a novel 6,11-bridged bicyclolide, against respiratory pathogens, including macrolide-resistant Gram-positive cocci","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425174217_DKU344C17","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/jac\/dkp098","article-title":"Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes","volume":"63","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425174217_DKU344C18","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1128\/AAC.02093-13","article-title":"First three Neisseria gonorrhoeae isolates with high-level resistance to azithromycin in Sweden: a threat to currently available dual-antimicrobial regimens for treatment of gonorrhea?","volume":"58","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425174217_DKU344C19","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1128\/AAC.01270-08","article-title":"Pharmacokinetics of EDP-420 after ascending single oral doses in healthy adult volunteers","volume":"53","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425174217_DKU344C20","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1128\/AAC.00022-09","article-title":"Pharmacokinetics of EDP-420 after multiple oral doses in healthy adult volunteers and in a bioequivalence study","volume":"53","year":"2009","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T19:47:48Z","timestamp":1498160868000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dku344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,1]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,9,1]]},"published-print":{"date-parts":[[2015,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dku344","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,1]]}}}